Indication
Multi-Organ Failure
2 clinical trials
2 products
1 drug
Clinical trial
Single-center, Open-label, Prospective Randomized (Double-Blind) Study on the Use of ReliZORB™ for the Treatment of Feeding Intolerance in Critically Ill Adults With Multi Organ FailureStatus: Withdrawn, Estimated PCD: 2023-07-30
Product
RelizorbClinical trial
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilogram(kg)/Minute(Min)) in Trauma Patients With Haemorrhagic Shock Induced Endotheliopathy.Status: Completed, Estimated PCD: 2021-11-14
Product
IloprostDrug
Varlilumab